menu toggle

Educational Podcasts for GPO Members

OnCall

Podcast Mic with Monitor bw

The education you want - wherever you want.

OnCall is a podcast series from AmerisourceBergen where we will discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice management solutions and the legislative landscape. Listen from your computer during breaks at the office or from your phone on the go - we make it easy to fit educational content into your schedule.

Featured episodes

The Basics of Bispecifics Podcast

In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they give an overview on the basics of bispecifics.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

 

Episode archives

May 2026

Q1 2026 GPO Legislative Townhall Webinar

In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include the 2026 legislative outlook, drug policy updates, market consolidation issues, and physician payment issues.

April 2026

Operationalizing Radiopharmace-uticals in Your Practice podcast

In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us a rundown on operationalizing radiopharmaceuticals in your practice.

April 2026

Radiopharmace-

uticals: Billing and Reimbursement podcast

In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an overview on billing and reimbursement of radiopharmaceuticals.

March 2026

Radiopharmace-

uticals Landscape podcast

In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an overview on the landscape surrounding radiopharmaceuticals.
 

February 2026

Introduction to Radiopharmace-uticals podcast

In this episode, Cencora's Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an introduction to the basics of radiopharmaceuticals.

January 2026

Q4 2025 GPO Legislative Townhall podcast

In this episode, Joel White, Partner and Head of Health at Monument Advocacy, talks about updates on DC legislative and regulatory issues, what to expect in 2026 for physician and hospital payments and the Rural Health fund, drug reimbursement and what to expect when IRA prices go live January 1, 2026, and Obamacare subsidies and what happens if they expire.

October 2025

Q3 GPO Legislative Townhall podcast

In this episode, Joel White, Partner and Head of Health Practice at Monument Advocacy, will discuss the Medicare physician fee schedule proposed rule and impact on practices and manufacturers, end of the year health priorities for congress, and Trump Administration goals, plans and efforts on drug pricing/MFN.

August 2025

Inflation Reduction Act: Current State podcast

In this episode, Whitley Quan, Manager of Cencora's U.S. Public Policy will be speaking on the current state of IRA implementation and what Cencora is doing to help its customer prepare for IRA deadlines.

July 2025

Inflation Reduction Act: Overview Podcast

In this episode, the first of our new Inflation Reduction Act series, Cencora's VP of Market Economics, Tyler Novotny, and Megan Law, Sr. Director of Specialty GPO Portfolio Accounts, will give an overview of IRA and dive into IRA impact on patients, manufacturers, and providers.

June 2025

Q2 Legislative Townhall Podcast

In this episode, Joel White, President and CEO of Horizon Government Affairs will be speaking on budget bill and payment updates for physicians, CMMI reforms for value-based care, CMS focus on technology assisted care, and drug price reforms.
 

May 2025

505(b)(2) Operationalizing in Practice - Provider Perspective Podcast 

In this episode, the final of our 505(b)(2) series, sponsored by Avyxa, we are joined by Dr. Fred Divers, Chief Medical Officer for American Oncology Network, and Dr. Ralph Boccia, hematologist oncologist, member of American Oncology Network, and the International Oncology Network's Chief Medical Officer, who will discuss operationalizing in practice from a provider perspective.

May 2025

505(b)(2) Operationalizing in Practice - Pharmacist Perspective Podcast

In this episode, the fourth of our 505(b)(2) series, sponsored by Avyxa, we are joined by James Gilmore, Chief Pharmacy and Clinical Services Officer at American Oncology Network, and Joe Shupp, VP of Sales for Cencora's ION Oncology Network, who will discuss operationalizing in practice from a pharmacist perspective.

April 2025

505(b)(2) Billing and Reimbursement 

In this episode, the third of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Trey McNiel, Senior Director of Sales for Cencora's ION Oncology Network East Region, discuss billing and reimbursement of 505(b)(2)s.

April 2025

505(b)(2) Landscape and Pipeline

In this episode, the second of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Matthew Letow, Senior Director of Sales New Business Development for Cencora's SAN GPO National Accounts, who will discuss the landscape and pipeline of 505(b)(2)s.

March 2025

505(b)(2) Basics

In this episode, the first of our 505(b)(2) series, sponsored by Avyxa, we are joined by Zach Horstman, Director of Specialty GPO Corporate Accounts for Cencora, and Yoni Resnick, Director of Pharmacy Clinical Services at New England Cancer Specialists, who will discuss the basics of 505(b)(2)s.

February 2025

Buy and Bill: Practice Perspective

In this episode, we are joined by Cencora's Specialty Practice Network National Senior Director of Sales for Immunology, Chara Reid, VP Sales for Cencora's Specialty Practice Network, Kortney Cooper, and Elizabeth Johnson, CEO of MedicoCX, who will discuss how buy and bill is implemented in MedicoCX practices.

January 2025

Buy and Bill: The Basics

In this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill.

Buy and bill presentation

January 2025

GPO 101: Legislative Townhall

In this OnCall episode, we are joined by Joel White, President of Horizon Government Affairs, who will discuss the Inflation Reduction Act, PBM reform, drug shortages, Medicare physician payment and telehealth issues.

June 2024

Biosimilar Basics: Payer Perspective

In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective.

May 2024

Biosimilar Basics: Legislation

In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars.

May 2024

Biosimilar Basics: Market Landscape

In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in the market.

April 2024

Biosimilar Basics: Overview

In this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss Biosimilars 101 and resources to utilize to stay better informed.

December 2023

GPO Legislative Townhall: Part 11

In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and shortages.

December 2023

GPO Legislative Townhall: Part 10

In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the House, competition, and lower costs on drugs and services.

December 2023

GPO Legislative Townhall: Part 9

In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around Medicare physician payment, and PBM reform.

August 2023

GPO Legislative Townhall: Part 8

In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections.

August 2023

GPO Legislative Townhall: Part 7

In this episode, the seventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses Congress and the fiscal backdrop.

May 2023

GPO Legislative Townhall: Part 6

In this episode, the sixth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the new DEA proposed rules on prescribing controlled substances and treatments.

May 2023

GPO Legislative Townhall: Part 5

In this episode, the fifth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the End of the Public Health Emergency and what it means for practices.

May 2023

GPO Legislative Townhall: Part 4

In this episode, the fourth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses federal budget and debt negotiations and the implications for Medicare, Medicaid and ACA.

February 2023

GPO Legislative Townhall: Part 3

In this episode, the third of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss the Inflation Reduction Act, PBM reform, and 2023 regulations.

February 2023

GPO Legislative Townhall: Part 2

In this episode, the second of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss drug coverage, pricing, and payment.

February 2023

GPO Legislative Townhall: Part 1

In this episode, the first of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss three important policy trends impacting physicians: Medicare payments, drugs/biologics, and disparities/SDOH.

September 2022

Biosimilar Series: Part 5

In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for biosimilars versus their counterparts. 

September 2022

Biosimilar Series: Part 4

In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the payer in relation to biosimilars, the formulary management process and the differences in treatment of biosimilars by Medicaid and Medicare. 

August 2022 

Biosimilar Series: Part 3

In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval process for biosimilars, the Biologics Price Competition and Innovation Act and safety issues or adverse effects related to biosimilar use. 

July 2022

Biosimilar Series: Part 2

In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the history of biosimilars, the reception of them in the medical community and their road ahead. 

July 2022

Biosimilar Series: Part 1

In this episode, the first of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss what biosimilars are (and aren’t), interchangeability with their reference products, and Kathy’s experience with adopting them into her practice.

April 2022

Biomarkers: Emerging Targets and Technologies

In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the importance of emerging biomarkers to basket and umbrella trial designs.

April 2022

Biomarker Testing: A Closer Look at When, Who, and How to Test

In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the advantages and disadvantages of liquid biopsies to the benefits of ordering test panels.

March 2022

Germline Genetic Testing

In this podcast series brought to you by Invitae, oncology specialists who routinely integrate genetic information into their patients' treatment, discuss actionable options for implementing genomics-informed, personalized cancer care.
In the first installment of this series, Dr. Rakesh Patel, Chief Medical Officer, Digital Health, and Dr. Peter Beitsch, Breast Surgical Oncologist, Past President of the American Society of Breast Surgeons, discuss common barriers for integrating genetic testing, and emerging digital health tools that can help health care practitioners scale the use of genomic information to help their patients.
The content and information contained in this podcast is sponsored by Invitae. This podcast is for educational, and informational purposes only. This podcast does not constitute medical or other professional advice or services. No person should act or refrain from acting on the basis of content provided in any podcast or website without first seeking appropriate medical advice and counseling. The opinions expressed in this podcast are the opinions of the individual and may not reflect the opinions of AmerisourceBergen or Invitae.

January 2022

Biomarkers 101: Basics of Biomarker Testing

In this episode, a part of our biomarker testing series, I’m joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about the basics of biomarker testing – from identifying common testing approaches to comparing DNA and RNA sequencing.

August 2021

Treating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AML

Listen to a discussion between Jonathan Abbas, MD, and Mark Levis, MD, PhD. 

Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at the end of this presentation. Please visit TibsovoPro.com to review the Full Prescribing Information, including BOXED WARNING.

November 2021

Novel Agents and Toxicity Management 101

In this episode, we are joined by Dr. Ian Olver, medical oncologist, bioethicist, researcher and current Professorial Research Fellow in the School of Psychology at the University of Adelaide, to discuss strategies and tools to support community oncologists in keeping patients on effective drugs by better managing the associated toxicities.

October 2021

Using AI Clinical Decision Support to Manage Cancer Complexity

In this episode, we are joined by Dr. Fred Ashbury, co-founder and chief scientific officer at Viecure, to highlight the key areas where A.I. significantly improves your ability to treat patients effectively and efficiently while also adding value to your practice.

October 2021

Paradigms, Policy and Pharmaco-genomics

In this episode, we are joined by Dr. Howard McLeod and Dr. Jai Patel who dive into the paradigm shift in cancer care, the role of genomic testing and sequencing, and navigating policy to your practice’s advantage.

September 2021

Clinical trials: How has precision medicine elevated the role of community oncology?

In this podcast, we talk about why, how and what’s in it for your practice to facilitate clinical trials in the community setting.

July 2021

Off Our Chests: A Discussion with Dr. John and Liza Marshall

In this episode, we met with Dr. John Marshall, a medical oncologist, Georgetown University professor and frequent guest speaker at ION Solutions events, and his wife, Liza Marshall, to discuss their book, “Off Our Chests: A Candid Tour Through the World of Cancer”.

May 2021

Precision Medicine Evolution, Pt 2

In this episode Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, and Nicole Chambers, Senior Director of Corporate Services for ION Solutions, discuss the advancements in liquid and tissue biopsy testing as well as the improvements our partners are making in the precision medicine space.

March 2021

Precision Medicine Evolution, Pt 1

Susan Weidner, Senior VP of IntrinsiQ  Analytics, and Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, discuss the overall strategy for ION’s precision medicine program - from the creation of the Precision Medicine Advisory Panel to where we are headed in the future.

March 2021

A Conversation with Annexus Health

Brian Ansay, President of ION and IPN Solutions, sat down with Joe Baffone, Co-Founder and CEO of Annexus Health, to discuss our partnership and the exciting opportunities available to our members.

December 2020

Precision Medicine Center

Nicole Chambers, Senior Director of Corporate Services at ION Solutions, and Carol Riley, Practice Manager at St. Louis Cancer Care, will discuss the creation of the Precision Medicine Center, ION’s centralized library of Precision Medicine testing recommendations, and its regular use within the processes of one of our practices.